RARRES2P6

Across TCGA pan-cancer cohorts, RARRES2P6 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RARRES2P6’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RARRES2P6 RNA is repressed in tumor relative to normal tissue. In most cancer types RARRES2P6 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA, HNSC, and LIHC are the cancer types where RARRES2P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RARRES2P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.120	<.001	6	view →
HNSC	All	II,III,IV	+0.089	.023	4	view →
LIHC	All	All	+0.296	.007	2	view →
LUSC	All	All	+0.169	.003	2	view →
KIRC	All	All	+0.011	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RARRES2P6–BRCA

Open the BRCA breakdown →